Bu Chang Pharmaceutical's subsidiary, Zhejiang Tianyuan, has been selected to participate in a national science and technology major project focused on developing an AIDS vaccine. The project involves the production and initial clinical trial application for the vaccine. Separately, *ST Wentai is dealing with ongoing legal challenges regarding its control over its subsidiary, Amkor Semiconductor, following a ruling from the Amsterdam Court of Appeal. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON The cluster contains information about participation in a national science and technology project for vaccine development, which falls under research. [lever_c_demoted from research: ic=1 ai=0.1]